Mutations in RAB39B are a known cause of X-linked early onset Parkinson's disease. Isogenic human embryonic stem cell lines carrying two independent deletions of RAB39B were generated using CRISPR/Cas9 genome editing tool. The deletions were confirmed by PCR and direct sequence analysis in two edited stem cell lines. Both cell lines showed pluripotency and displayed a normal karyotype. Further, they were able to form embryoid bodies in vitro, and express markers indicative of differentiation to the three germ layers.
Pubmed ID: 29499499 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets IgG (H+L)
View all literature mentionsThis polyclonal targets Human/Mouse Brachyury Affinity Purified Ab
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentionsThis monoclonal targets Pax6
View all literature mentionsThis monoclonal targets CD326
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis polyclonal targets Nanog
View all literature mentionsThis monoclonal targets Human SOX2
View all literature mentionsThis monoclonal targets Human Oct-4A MAb (Clone 653108)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis monoclonal targets Pax6
View all literature mentionsThis polyclonal targets Human/Mouse Brachyury Affinity Purified Ab
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentionsThis monoclonal targets Pax6
View all literature mentionsThis polyclonal targets Human/Mouse Brachyury Affinity Purified Ab
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentions